EuroIntervention/X
Jun 30, 2025, 15:19
Study Explored the Use of Paclitaxel-Coated Balloons for Stabilizing Vulnerable Lipid-Rich Plaques in ACS Patients – EuroIntervention
EuroIntervention shared on X:
“This study explored the use of paclitaxel-coated balloons for stabilizing vulnerable lipid-rich plaques in ACS patients. Discover how this approach could reduce future coronary events.”
Title: Paclitaxel-coated balloons for vulnerable lipid-rich plaques.
Authors: Anna van Veelen, I. Tarik Küçük, Hector M. García-García, Federico H. Fuentes, Yirga Kahsay, Ronak Delewi, Marcel A.M. Beijk, Alexander W. den Hartog, Maik J. Grundeken, M. Marije Vis, José P.S. Henriques, Bimmer E.P.M. Claessen.
Read the full research.
You can find more posts on Hemostasis Today.
-
Apr 11, 2026, 13:51David McIntosh: Vital Plasma Derived Medicines – The Anomalous UK Scene
-
Apr 11, 2026, 13:47Samrawit Terefe: O Negative Blood Is the Universal Donor With Extreme Scarcity
-
Apr 11, 2026, 13:39Dheeraj Garg: Rethinking Cardiovascular Disease – A Cardiologist’s Perspective
-
Apr 11, 2026, 13:37Kushal Bhatia: Is The 4.5-Hour Thrombolysis Window Officially Outdated?
-
Apr 11, 2026, 13:35William Aird: Why Did Mammalian Red Blood Cells Give Up Their Nucleus?
-
Apr 11, 2026, 13:30Ken Kuang: Gravity Is Constant, But Your Vein Health Doesn’t Have to Be
-
Apr 11, 2026, 13:21Mascha Kern: Measuring Gender’s Role in Stroke and Migraine
-
Apr 11, 2026, 13:10Danique Steeghs: Key Findings from a Microfluidic Chemiluminescent Thrombin Generation Assay
-
Apr 11, 2026, 13:06Shanvi Mahi: A Validated Tool to Explore Lived Experiences After Stroke Rehabilitation